What is NDC 71656-030?

71656-030 is the product NDC for erythromycin topical solution 2%, Erythromycin 20 mg/mL solution, listed with the FDA by Saptalis Pharmaceuticals, LLC LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Saptalis Pharmaceuticals, LLC LLC, NDC labeler code 71656. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for erythromycin topical solution 2%?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

erythromycin topical solution 2% NDC 71656-030

NDC codes

FDA NDC Directory

Product NDC (as listed)71656-030Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71656-0030Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71656-030-60	7165600306071656003060	1 BOTTLE in 1 CARTON (71656-030-60) / 60 mL in 1 BOTTLEMarketed from Aug 14, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): erythromycin topical solution 2%
Generic name (nonproprietary): erythromycin topical solution 2%
Active ingredients: Erythromycin — 20 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Saptalis Pharmaceuticals, LLC LLCNDC labeler code 71656
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 062687
Marketing start: Aug 14, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Macrolides (Chemical structure)
Identifiers: Product ID 71656-030_21b6729d-f82f-309a-e063-6394a90a8a36SPL ID 21b6729d-f82f-309a-e063-6394a90a8a36SPL set ID 21b64a3f-2c95-1c1a-e063-6294a90a0ea0RxCUI 318202UNII 63937KV33DUPC 0371656030605
Pharmacologic class: Macrolide Antimicrobial; Macrolide

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471656003060 followed by a unit qualifier and the quantity

Package 71656-0030-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 14, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Erythromycin topical solution, 2% is indicated for the topical treatment of acne vulgaris.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71656-030

What is NDC 71656-030?: 71656-030 is the product NDC for erythromycin topical solution 2%, Erythromycin 20 mg/mL solution, listed with the FDA by Saptalis Pharmaceuticals, LLC LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: erythromycin topical solution 2%.
What is the active ingredient?: Erythromycin.
Who is the labeler?: Saptalis Pharmaceuticals, LLC LLC, NDC labeler code 71656. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for erythromycin topical solution 2%?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.